Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06487117Phase 1Not yet recruiting
Phase 1, randomised trial of Huafu Shengji Ointment in diabetic foot ulcer (DFU) (2 arms), sponsored by Beijing Daxing District Hospital of Integrated Chinese and Western Medicine. Primary endpoints: ulcer area at 8 weeks, granulation tissue coverage at 8 weeks and 2 more. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06487117.